受体酪氨酸激酶AXL在肿瘤中的研究进展 |
| |
引用本文: | 唐小崧. 受体酪氨酸激酶AXL在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2017, 0(3): 281-284. DOI: 10.11904/j.issn.1002-3070.2017.03.019 |
| |
作者姓名: | 唐小崧 |
| |
作者单位: | 哈尔滨医科大学附属肿瘤医院内一科 哈尔滨150081 |
| |
摘 要: | AXL是TAM受体酪氨酸激酶家族中的一员,AXL已经被证实与肺癌、乳腺癌、甲状腺癌、前列腺癌和胰腺癌等多种癌症有关.最新证据显示,AXL可促进多种肿瘤的生长、侵袭、转移,其抑制剂可抑制肿瘤形成,这说明AXL可能成为抗肿瘤治疗的潜在靶点,AXL激酶抑制剂的应用可能成为抗肿瘤治疗的新策略.本文对AXL与肿瘤方向的研究进展做一综述.
|
关 键 词: | 受体酪氨酸激酶 AXL 肿瘤 ALX激酶抑制剂 |
Research progress of receptor tyrosine kinase AXL in tumor |
| |
Abstract: | AXL is a member of the TAM receptor tyrosine kinase family,and AXL has been shown to beassociated with a variety of cancers such as lung cancer,breast cancer,thyroid cancer,prostate cancer and pancre-atic cancer.The latest evidence suggests that AXL can promote the growth,invasion and metastasis of varioustumors,and its inhibitors can also inhibit tumor formation,suggesting that AXL may be a potential target for anti-tumor therapy,and the use of AXL kinase inhibitors may become the new strategy of anti-tumor therapy.This ar-ticle reviews the progress of AXL and tumor. |
| |
Keywords: | Receptor tyrosine kinase AXL Tumor AXL kinase inhibitors |
本文献已被 万方数据 等数据库收录! |
|